LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 302

Search options

  1. Article ; Online: Concise Commentary: Ozanimod in Real Life-Plus ça Change, Plus C'est la Même Chose.

    Fiorino, Gionata / Allocca, Mariangela / Danese, Silvio

    Digestive diseases and sciences

    2023  Volume 69, Issue 2, Page(s) 322–323

    MeSH term(s) Humans ; Indans ; Oxadiazoles
    Chemical Substances ozanimod (Z80293URPV) ; Indans ; Oxadiazoles
    Language English
    Publishing date 2023-12-12
    Publishing country United States
    Document type Editorial
    ZDB-ID 304250-9
    ISSN 1573-2568 ; 0163-2116
    ISSN (online) 1573-2568
    ISSN 0163-2116
    DOI 10.1007/s10620-023-08179-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The new frontier: Certifying quality standards in the inflammatory bowel disease care.

    Fiorino, Gionata / Danese, Silvio

    United European gastroenterology journal

    2021  Volume 9, Issue 7, Page(s) 745–747

    MeSH term(s) Chronic Disease ; Colitis, Ulcerative ; Humans ; Inflammatory Bowel Diseases/diagnosis ; Inflammatory Bowel Diseases/therapy
    Language English
    Publishing date 2021-07-10
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 2728585-6
    ISSN 2050-6414 ; 2050-6406
    ISSN (online) 2050-6414
    ISSN 2050-6406
    DOI 10.1002/ueg2.12122
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Editorial: treat-to-target in ulcerative colitis clinical management-a small price to pay? Authors' reply.

    Cortesi, Paolo Angelo / Fiorino, Gionata / Mantovani, Lorenzo Giovanni / Danese, Silvio

    Alimentary pharmacology & therapeutics

    2023  Volume 57, Issue 5, Page(s) 571–572

    MeSH term(s) Humans ; Colitis, Ulcerative/drug therapy
    Language English
    Publishing date 2023-02-14
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 639012-2
    ISSN 1365-2036 ; 0269-2813 ; 0953-0673
    ISSN (online) 1365-2036
    ISSN 0269-2813 ; 0953-0673
    DOI 10.1111/apt.17375
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: At the Crossroads of Caution and Intervention: Anti-TNF Therapy Prior to Elective CD Surgery.

    Adamina, Michel / Fiorino, Gionata

    Journal of Crohn's & colitis

    2021  Volume 15, Issue 10, Page(s) 1778–1779

    MeSH term(s) Adalimumab/adverse effects ; Crohn Disease ; Humans ; Infliximab ; Postoperative Complications ; Tumor Necrosis Factor Inhibitors
    Chemical Substances Tumor Necrosis Factor Inhibitors ; Infliximab (B72HH48FLU) ; Adalimumab (FYS6T7F842)
    Language English
    Publishing date 2021-05-08
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 2390120-2
    ISSN 1876-4479 ; 1873-9946
    ISSN (online) 1876-4479
    ISSN 1873-9946
    DOI 10.1093/ecco-jcc/jjab092
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Could small molecules be used in combination with biologics for inflammatory bowel disease?

    D'Amico, Ferdinando / Danese, Silvio / Fiorino, Gionata

    Expert review of clinical immunology

    2022  Volume 18, Issue 10, Page(s) 991–993

    MeSH term(s) Biological Products/therapeutic use ; Chronic Disease ; Colitis, Ulcerative ; Humans ; Inflammatory Bowel Diseases/drug therapy
    Chemical Substances Biological Products
    Language English
    Publishing date 2022-08-02
    Publishing country England
    Document type Editorial
    ZDB-ID 2274260-8
    ISSN 1744-8409 ; 1744-666X
    ISSN (online) 1744-8409
    ISSN 1744-666X
    DOI 10.1080/1744666X.2022.2104713
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?

    D'Amico, Ferdinando / Zilli, Alessandra / Fiorino, Gionata

    United European gastroenterology journal

    2022  Volume 10, Issue 2, Page(s) 141–142

    MeSH term(s) Colitis, Ulcerative ; Electronics ; Endoscopy, Gastrointestinal ; Humans ; Inflammatory Bowel Diseases/diagnosis ; Inflammatory Bowel Diseases/pathology
    Language English
    Publishing date 2022-01-22
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 2728585-6
    ISSN 2050-6414 ; 2050-6406
    ISSN (online) 2050-6414
    ISSN 2050-6406
    DOI 10.1002/ueg2.12202
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice Experiment.

    Fiorino, Gionata / Bent-Ennakhil, Nawal / Varriale, Pasquale / Braegger, Fiona / Hoefkens, Eveline

    Inflammatory bowel diseases

    2024  

    Abstract: Background: Inflammatory bowel disease requires long-term treatment; therefore, understanding patient preferences is important in aiding informed treatment decision making. This study explored patients' preferences for treatment attributes of available ... ...

    Abstract Background: Inflammatory bowel disease requires long-term treatment; therefore, understanding patient preferences is important in aiding informed treatment decision making. This study explored patients' preferences for treatment attributes of available inflammatory bowel disease therapies.
    Methods: Adult patients from 7 European countries who self-reported previous/current treatment for Crohn's disease (CD) or ulcerative colitis (UC) participated in an online survey via the Carenity platform. In a discrete choice experiment, the relative importance of treatment attributes for CD and UC was estimated using conditional logit models. Latent class analysis was conducted to estimate heterogeneous treatment preferences based on patient profiles. Patients' perspectives and preferences regarding their quality of life were assessed.
    Results: Across 686 completed survey responses (CD, n = 360; UC, n = 326), the mean patient age was 48 and 50 years, respectively. Patients with CD ranked route of administration as the most important attribute (attribute importance: 32%), preferring subcutaneous over intravenous treatment (P < .001). Patients with UC ranked route of administration and frequency of serious adverse events as the most important attributes (attribute importance: 31% and 23%, respectively), preferring oral (P < .001) and subcutaneous (P < .001) over intravenous treatment and treatment that minimized the risk of serious adverse events (P < .001) or mild adverse events (P < .01). Latent class analyses confirmed the impact of patients' sociodemographic profile on their preferences. All patients prioritized general well-being, energy level, and daily activities as the most important aspects for improvement through treatment.
    Conclusions: Patient preferences for treatment attributes varied among patients with CD or UC, highlighting the importance of personalized care and shared decision making to maximize treatment benefits.
    Language English
    Publishing date 2024-03-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 1340971-2
    ISSN 1536-4844 ; 1078-0998
    ISSN (online) 1536-4844
    ISSN 1078-0998
    DOI 10.1093/ibd/izae015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Adalimumab biosimilar in inflammatory bowel disease.

    Fiorino, Gionata / Allocca, Mariangela / Danese, Silvio

    The lancet. Gastroenterology & hepatology

    2021  Volume 6, Issue 10, Page(s) 775–776

    MeSH term(s) Adalimumab/therapeutic use ; Biosimilar Pharmaceuticals/therapeutic use ; Colitis ; Humans ; Inflammatory Bowel Diseases/drug therapy ; Infliximab
    Chemical Substances Biosimilar Pharmaceuticals ; Infliximab (B72HH48FLU) ; Adalimumab (FYS6T7F842)
    Language English
    Publishing date 2021-08-11
    Publishing country Netherlands
    Document type Journal Article ; Comment
    ISSN 2468-1253
    ISSN (online) 2468-1253
    DOI 10.1016/S2468-1253(21)00266-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Positioning Ozanimod in Ulcerative Colitis: Restoring Leukocyte Traffic Under Control.

    D'Amico, Ferdinando / Allocca, Mariangela / Fiorino, Gionata

    Gastroenterology

    2021  Volume 162, Issue 6, Page(s) 1767–1769

    MeSH term(s) Colitis, Ulcerative/diagnosis ; Colitis, Ulcerative/drug therapy ; Humans ; Indans ; Leukocytes ; Oxadiazoles
    Chemical Substances Indans ; Oxadiazoles ; ozanimod (Z80293URPV)
    Language English
    Publishing date 2021-12-08
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 80112-4
    ISSN 1528-0012 ; 0016-5085
    ISSN (online) 1528-0012
    ISSN 0016-5085
    DOI 10.1053/j.gastro.2021.12.235
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Epidemiology and clinical course of late onset inflammatory bowel disease.

    Viola, Anna / Fiorino, Gionata / Costantino, Giuseppe / Fries, Walter

    Minerva gastroenterology

    2021  Volume 70, Issue 1, Page(s) 52–58

    Abstract: With the increasing age of the general population in developed countries, the management of several chronic diseases becomes more and more complex due to comorbidities. Some, especially inflammatory bowel diseases, formerly believed to belong to the ... ...

    Abstract With the increasing age of the general population in developed countries, the management of several chronic diseases becomes more and more complex due to comorbidities. Some, especially inflammatory bowel diseases, formerly believed to belong to the young adult population, have now been recognized as being present at disease onset also in the ageing population, representing medical challenges different from those in the younger population. In the past few years, knowledge on this special older population has increased, changing initial beliefs concerning epidemiology and course of disease. In the present review, we addressed the most recent evidence concerning their current incidence compared with other age groups, their clinical course, potential risk factors for the development of late-onset IBDs, associated diseases, and cancer risk beyond therapy-related neoplasias.
    MeSH term(s) Young Adult ; Humans ; Inflammatory Bowel Diseases/epidemiology ; Incidence ; Risk Factors ; Neoplasms ; Disease Progression
    Language English
    Publishing date 2021-05-31
    Publishing country Italy
    Document type Review ; Journal Article
    ZDB-ID 3062713-8
    ISSN 2724-5365
    ISSN (online) 2724-5365
    DOI 10.23736/S2724-5985.21.02890-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top